Marstacimab‑Hncq Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 150 mg/mL
Reference Brands: Hympavzi (USA)
Category:
Plasma Products
Marstacimab-hncq is a human monoclonal IgG1 antibody that antagonizes the tissue factor pathway inhibitor (TFPI), thereby promoting thrombin generation and improving clot formation in patients with haemophilia A or B without inhibitors.
It is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and adolescents (≥ 12 years) with haemophilia A without factor VIII inhibitors or haemophilia B without factor IX inhibitors.
Marstacimab‑hncq is available in injection (prefilled syringe)
and strengths such as 150 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Marstacimab‑hncq is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Marstacimab‑hncq can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing